ACPU
PACB icon

Arrowgrass Capital Partners (US)’s Pacific Biosciences PACB Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-565,778
Closed -$3.42M – 269
2019
Q2 		$3.42M Buy
565,778
+423,276
+297% +$2.97M 0.08% 220
2019
Q1 		$1.03M Sell
142,502
-47,949
-25% -$347K 0.03% 291
2018
Q4 		$1.41M Buy
+190,451
New +$1.21M 0.05% 220

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s PACB Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Pacific Biosciences (PACB) in Q3 2019, closing a stake of 565,778 shares — an estimated $3.42M sold.

Arrowgrass Capital Partners (US) first reported a position in PACB in Q4 2018 and held it in 3 quarters. The position peaked at $3.42M in Q2 2019. 148 funds tracked by Wall St. Rank hold PACB as of Q3 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Pacific Biosciences position as of Q3 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 565,778 Pacific Biosciences shares in Q3 2019, an estimated $3.42M.
  • Arrowgrass Capital Partners (US) first reported a position in Pacific Biosciences in Q4 2018 and held it in 3 quarters.
  • Arrowgrass Capital Partners (US)'s Pacific Biosciences position peaked at $3.42M in Q2 2019.
  • 148 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.